Pfizer and Novartis post profits that beat Covid-19 hospital disruptions       

Pfizer reported quarterly earnings that beat estimates, helped by better-than-expected sales of its cancer drug Ibrance

Pfizer Inc says they are not ready to release data on their late-stage trial of a Covid-19 vaccine. File picture: Scott Eisen/Bloomberg

Drugmaker Pfizer said it was not yet ready to release data from the late-stage trial of the Covid-19 vaccine candidate it is developing with Germany's BioNTech.

It comes as Pfizer and rival Novartis both reported sales of conventional drugs that have been disrupted by the Covid crisis.